Diverticular disease and gut microbiota modulation: a focus on probiotics
Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini · 2026-04 · 2026 (1) · 87-91
DOI: 10.15407/internalmed2026.01.087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, 2026-04. Verfasst von O.I. Sergienko und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
The article presents a modern description of the phenotypes of diverticular disease. The risk factors of diverticular disease, the features of the course of the disease and the ethical role of the intestinal microbiota are highlighted. The feasibility of using probiotics and metabiotics based on short-chain fatty acids, butyrate and inulin in the treatment of diverticular disease is substantiated.
Zitieren
APA
Sergienko, O., Chernobai, A., Tegelska, G., Novokhatnya, A., & Sikalo, Y. (2026). Diverticular disease and gut microbiota modulation: a focus on probiotics. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini, 2026(1), 87-91. https://doi.org/10.15407/internalmed2026.01.087
Vancouver
Sergienko O, Chernobai A, Tegelska G, Novokhatnya A, Sikalo Y. Diverticular disease and gut microbiota modulation: a focus on probiotics. Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini. 2026;2026(1):87-91. doi:10.15407/internalmed2026.01.087
BibTeX
@article{Sergienko2026,
author = {Sergienko, O.I. and Chernobai, A.I. and Tegelska, G.Yu. and Novokhatnya, A.I. and Sikalo, Yu.K.},
title = {Diverticular disease and gut microbiota modulation: a focus on probiotics},
journal = {Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini},
year = {2026},
volume = {2026},
number = {1},
pages = {87--91},
doi = {10.15407/internalmed2026.01.087}
}
EUVIMED